IJD(®) 2014: Marching Ahead.

The year started on a sombre mode. We lost our past editor, Dr. Baidyanath Haldar, one of the most renowned dermatologists from this part of the globe. His name will be etched in the history of Indian Journal of Dermatology for his tireless efforts to revive the journal in the mid-90s of the last century. We pay our heartfelt regards and tributes to this doyen.

For any journal of repute consistency and regularity of publication is of paramount importance. Thanks to our dedicated team IJD we made the punctuality a habit and all the issues of 2014 could be released days before the month started.

The Indian Journal of Dermatology (IJD®) QUIZ is creating waves with each issue. We are grateful to Ranbaxy for supporting this academic endeavor. Within minutes, a new IJD® QUIZ is uploaded each time our mailbox starts receiving a shower of responses. Within the first 24 h we receive almost half of the answers. The results were declared on time, all the time on 1st of the next month.

It would be pertinent to mention here about the other lucrative rewards offered like IJD® Ranbaxy awards for best original article and best case report. IJD-ISPD award is given for best article on pediatric dermatology published in IJD® in any particular year and also IJD-CODFI award for the best paper published on occupational and contact dermatitis for that year.

All the vital publication indicators like SCImago Journal Ranking cites per doc, total cites, total citable documents and the percentage of cited documents continued to show a very healthy and steady upward swing. Two-year citation per document is equivalent to journal impact factor™ (Thomsons Reuters) metric. The projected impact factor based on citation analysis of Wolters Kluwer Medknow has reached 0.935 [Figure 1].

Figure 1

Cites per Document in 2, 3 and 4 years windows: Evolution of Citations per Document to published documents of Indian Journal of Dermatology, during the two, three and four previous years. The two years line is equivalent to journal impact factor™ (Thomson Reuters) metric

Source - www.scimagojr.com

We could publish a never before number of articles this year based on which in 2014 we jumped 15 places and reached the 12th place among all the indexed Dermatology Journals of the world.

We are happy that in terms of percentage of cited documents and citable documents in 2013 IJD has surpassed all other Dermatology Journals published from India [Figures 2 and 3].

Figure 2

Cited documents per year in Indian Journal of Dermatology and Indian Journal of Dermatology, Venereology and Leprology

Source: www.scimagojr.com

Figure 3

Citable documents per year in Indian Journal of Dermatology and Indian Journal of Dermatology, Venereology and Leprology

Source: www.scimagojr.com

IJD® Symposium has already been recognized as an admired distinctiveness of the journal for its class and consistency. In 2014 we could bring out a historic symposium on Evidence-based Dermatology with our Executive Editor Dr. Saumya Panda as the chief architect of the same. Another symposium on the burning issue topical corticosteroid misuse by Dr. Arijit Coondoo has significantly expanded the horizon of the journal. New additions like IJD focus articles and separate sections on Investigative Dermatology and Dermatology in Internal Medicine are also to be mentioned.

In 2005, we observed a very successful IJD® GoldCon to commemorate the golden jubilee celebration of the journal. In the annual GB meeting of the parent body IADVL, West Bengal it has been unanimously decided to celebrate the Diamond Jubilee year in 2015 in a befitting manner by organizing IJD® DiamondCon.

Although the outcome is not always directly proportional to the effort exerted, I have nevertheless tried to offer the best that I can, with the help of the highly erudite, focused, and committed editorial board members, distinguished members of the editorial advisory board and extremely supportive executive committee of IADVL, West Bengal State Branch and Asian Academy of Dermatology and Venereology.

I take this opportunity to thank our sponsors, namely, Ranbaxy, Galderma, Palsons Derma, Ajanta (Zillion and Avecea), Gracewell, and Ipca Bionova who stood by us like pillars.

As we enter the historic Diamond Jubilee year as the first Dermatology Journal from Asia the journal is getting a completely new look with fresh layouts internally as well as externally. We thank Dr. Debabrata Bandopadhyay for his creative contribution behind another extensive overhaul.

Before I sign off let me share another good news with our readers. A couple of years back we were able to register IJD® as our official trademark. Very recently we have entered the final phase of registering our logo as well.

Like every year, on behalf of team IJD®, let me wish all of you a very happy, healthy, peaceful, prosperous and productive 2015.

Long live the Indian Journal of Dermatology (IJD®).